Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection

Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection

US Patent 11530268 · Granted Dec 20, 2022

Estimated economic value: $101,371,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Graphics processing unit processing and caching improvements2025
Antigenic multimeric respiratory syncytial virus polypeptides2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Chikungunya virus (CHIKV) virus-like particles (VLPS) comprising the C, E1, and 2025
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of 2025
Anti-CHIKV antibodies and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025
Trispecific binding proteins, methods, and uses thereof2025